Gut Microbiome VOC Data: A Complete Guide to Molecular Signals

Every day, trillions of bacteria in your colon carry on an intricate conversation conducted entirely in chemistry. They ferment plant fibers, break down amino acids, produce gases and synthesize metabolites that influence immune function and metabolic regulation. For most of the history of gastroenterology we could hear that conversation only indirectly, through symptoms, clinical markers or laboratory culture.

There is a more direct route. Your gut microbiome expresses itself in volatile organic compounds, molecules that escape into the gas phase and carry a chemical record of what the bacterial ecosystem has been building and breaking down. Garner and colleagues catalogued 297 such compounds in human fecal headspace, with 44 present in 80 percent of subjects (FASEB Journal, 2007). The shift this enables is fundamental: rather than asking only which bacteria live there, we can ask what the microbial community is actually doing.

What VOCs Are: A Chemistry Primer

Volatile organic compounds are organic molecules with high vapor pressure at room temperature and low water solubility. In plain terms, they evaporate easily and enter the gas phase, and that physical property is precisely what makes them useful for non-invasive monitoring.

The VOCs produced in the gut fall into several chemical classes:

• Alcohols, including ethanol and phenolic compounds, byproducts of particular fermentation pathways.
• Aldehydes such as acetaldehyde and benzaldehyde, intermediates in oxidation-reduction reactions that can indicate the oxidative state of the microbiota.
• Ketones such as acetone and 2-butanone, common fermentation products.
• Esters, volatile combinations of alcohols and organic acids often associated with specific metabolic specialization.
• Sulfur compounds including hydrogen sulfide, dimethyl sulfide and dimethyl disulfide, which originate from protein and amino acid fermentation.
• Indoles and related compounds including indole and skatole, aromatic molecules produced from tryptophan metabolism with real signaling roles in host-microbe communication.
• Short-chain fatty acids and their congeners, the volatile end of a broad class of bacterial metabolites with substantial health implications.

The table below maps each class onto its precursor, its main microbial producers and what a shift in that class typically indicates.

Compound class	Representative compounds	Dietary precursor	Principal producers	Interpretation of a rise
Short-chain fatty acids	Acetate, propionate, butyrate	Fermentable fiber, resistant starch	Faecalibacterium prausnitzii, Roseburia, Eubacterium rectale, Anaerostipes, Bacteroides	Active saccharolytic fermentation, epithelial fuel supply
Branched-chain fatty acids	Iso-butyrate, iso-valerate	Leucine, valine, isoleucine	Proteolytic Clostridium clusters	Protein fermentation displacing carbohydrate fermentation
Sulfur volatiles	Hydrogen sulfide, dimethyl sulfide, dimethyl disulfide	Dietary sulfate, cysteine, methionine	Desulfovibrio and other sulfate-reducing bacteria; cysteine-metabolizing taxa	Sulfur processing; at excess, mucus and barrier disruption
Indoles	Indole, skatole (3-methylindole)	Tryptophan	Tryptophanase-carrying taxa including Escherichia coli, Clostridium, Bacteroides	Tryptophan catabolism, higher protein intake
Phenolics	Phenol, p-cresol	Tyrosine, phenylalanine	Clostridium, Bacteroides	Aromatic amino acid fermentation; p-cresol is absorbed and excreted as p-cresyl sulfate
Volatile amines	Histamine, cadaverine, tyramine	Histidine, lysine, tyrosine	Decarboxylase-carrying taxa including some lactobacilli and enterobacteria	Amino acid decarboxylation as a dominant route
Methane	Methane	Hydrogen and formate generated by bacterial fermentation	Methanobrevibacter smithii and other methanogenic archaea	Hydrogen disposal by methanogenesis, often with slower transit

Detection has been largely standardized around headspace solid-phase microextraction coupled with gas chromatography-mass spectrometry (HS-SPME-GC-MS). This approach captures the volatile signature of a stool sample without requiring culture, and provides a high-resolution chemical fingerprint of metabolic activity. That precision is what lets us move past broad labels like dysbiosis and ask specifically which metabolic processes are running.

The Volatilome as a Functional Signature

Individual compounds are meaningful, but they are far more meaningful as a collective profile. The volatilome is the complete set of volatile compounds your gut ecosystem produces at a given moment, and it functions less like a list of chemicals and more like a chord: a single note tells you something, but the full chord tells you the tone.

What makes the volatilome powerful is that it reflects actual metabolic processes rather than genetic potential. The clearest demonstration comes from the TwinsUK cohort, where Zierer and colleagues measured 1,116 fecal metabolites across 786 individuals and found that host genetics explained only about 17.9 percent of the variation while gut microbial composition explained on average 67.7 percent (standard deviation 18.8 percent). Fecal metabolite profiles were also strongly associated with visceral fat mass (Zierer et al., Nature Genetics, 2018). The fecal metabolome is, in that specific and measured sense, a readout of the microbiome.

Volatilome-specific work points the same way. Calabrese and colleagues compared fecal volatilome and microbiota profiles across metabolically healthy and metabolically unhealthy obesity phenotypes and found volatile signatures that separated the two groups, distinctions that taxonomic composition alone did not capture as cleanly (Journal of Endocrinological Investigation, 2024).

This is why patterns matter more than individual markers. Your volatilome is an ecological signature. It indicates whether your microbiota is predominantly fermentative, putrefactive, methanogenic, or balanced across several pathways.

Key VOC Biomarkers and What They Indicate

Butyrate and Short-Chain Fatty Acids

Butyrate is arguably the single most important marker of a functional microbiota. It is a four-carbon short-chain fatty acid produced when bacteria ferment dietary fiber and resistant starch, and its volatility means it appears clearly in VOC profiles.

Measurements of colonic contents by Cummings and colleagues established the reference proportions still used today: acetate, propionate and butyrate occur at roughly a 60:20:20 molar ratio and together account for the great majority of the colonic short-chain fatty acid pool (Gut, 1987). Total concentrations in the proximal colon were reported in the region of 100 millimoles per litre, falling distally.

Colonocytes preferentially use butyrate as fuel, so butyrate production underwrites the energy budget of the intestinal epithelium and therefore barrier integrity. Butyrate is also an epigenetic signal: it inhibits histone deacetylases, altering gene expression, a mechanism thought to underlie its anti-inflammatory effects, and it supports the development of regulatory T cells that restrain excessive inflammation (Parada Venegas et al., Frontiers in Immunology, 2019; Mann et al., Nature Reviews Immunology, 2024).

Most butyrate comes from a relatively small set of species. Faecalibacterium prausnitzii is particularly important. Sokol and colleagues showed it is depleted in Crohn's disease and that both the organism and its culture supernatant reduced inflammation in experimental colitis, which is the classic demonstration that this is a functional relationship rather than a bystander association (PNAS, 2008). A strong butyrate signature suggests that F. prausnitzii and relatives such as Roseburia, Eubacterium rectale and Anaerostipes are thriving.

Hydrogen Sulfide and Sulfur Compounds

Hydrogen sulfide sits at the other end of the metabolic spectrum, though context matters intensely. It arises through two main routes: sulfate-reducing bacteria including Desulfovibrio species reducing dietary sulfate, and cysteine-metabolizing bacteria converting cysteine directly into hydrogen sulfide (Blachier et al., American Journal of Physiology-Gastrointestinal and Liver Physiology, 2021).

At physiological levels, hydrogen sulfide acts as a gasotransmitter involved in cell signaling, and some production is entirely normal. In dysbiotic states, however, excess production has been associated with disruption of the protective mucus layer, inflammation and barrier dysfunction. There is also emerging metabolic signal: Qi and colleagues reported that microbially produced hydrogen sulfide impaired host metabolism by reducing GLP-1 levels in male mice, an animal finding that has not yet been replicated in humans (Nature Metabolism, 2024). Dimethyl sulfide and dimethyl disulfide are downstream products of sulfide metabolism and mark active sulfur processing.

Moderate sulfur detection is expected. When sulfur volatiles dominate, especially alongside low butyrate and elevated putrefactive compounds, the profile suggests a shift toward protein degradation and away from carbohydrate fermentation, a pattern frequently reported alongside bloating, gas and digestive distress.

Indole and Skatole

Indole and skatole come from microbial metabolism of tryptophan. Certain bacteria carry tryptophanase enzymes that convert tryptophan into indole, which is volatile, contributes to stool odor, and also acts as a signaling molecule binding the aryl hydrocarbon receptor in a way that supports intestinal barrier function (Roager and Licht, Nature Communications, 2018). Skatole, or 3-methylindole, is produced downstream and is a notable contributor to odor on higher-protein diets. Li and colleagues review the downstream indole derivatives and their roles in intestinal and liver disease (Frontiers in Pharmacology, 2021).

These pathways describe diet-microbiota interaction, and the direction of that interaction is now experimentally supported. Sinha and colleagues showed that dietary fibre redirects microbial tryptophan metabolism through metabolic interactions within the community, shifting output toward indole-3-propionic acid and related metabolites rather than the more putrefactive products (Nature Microbiology, 2024). Higher dietary protein, particularly from animal sources, shifts the ratio the other way toward more indole and skatole.

Not every indolic compound is a warning sign, and not every one is benign. Phenolic and indolic products including p-cresol and indole are absorbed, conjugated in the liver and excreted renally as p-cresyl sulfate and indoxyl sulfate, which are among the best-characterized colon-derived uremic toxins in kidney disease (Evenepoel et al., Kidney International, 2009).

Methane and the Constipation Connection

Methane is not produced by bacteria at all but by methanogenic archaea, principally Methanobrevibacter smithii. This organism does not ferment carbohydrates directly; it consumes hydrogen and formate produced by bacterial fermentation and converts them into methane, providing an ecological service by removing accumulating hydrogen (Hoegenauer et al., Nature Reviews Gastroenterology & Hepatology, 2022).

Methane also has clear clinical associations. That review documents the consistent association between methane production and constipation, and with constipation-predominant rather than diarrhea-predominant irritable bowel syndrome, with the proposed mechanism being methane slowing intestinal transit. Methane detection in a VOC profile is therefore a specific marker worth noting, particularly alongside slow transit.

Volatile Amines

Volatile amines including histamine, cadaverine and tyramine are produced through amino acid decarboxylation by bacteria carrying the relevant enzymes. Histamine is particularly relevant for individuals who metabolize it poorly, where higher histamine-producing bacterial activity can correlate with symptoms. Polyamines such as spermidine and spermine are essential for normal cell function, though excessive production may tip toward inflammatory states in susceptible people. Amine detection helps identify whether bacterial amino acid decarboxylation is a dominant process, which is most informative when read against dietary protein intake.

Why Ecological Signatures Beat Single Markers

It is tempting to reduce this to high butyrate good, high sulfide bad. The reality is more nuanced, because your volatilome tells an ecological story. Three broad patterns recur in the literature.

Pattern	Butyrate signal	Sulfur volatiles	Methane	Volatile amines and indoles	Ecological reading
Saccharolytic	High	Low	Low	Low	Fiber fermentation dominant, putrefaction minimal
Putrefactive	Low	High	Variable	High	Protein degradation dominant, fermentation substrate limited
Methanogenic	Variable	Low to moderate	High	Moderate	Hydrogen disposal via archaea, frequently with slower transit
Transitional	Moderate	Moderate	Low	Moderate	Dietary change, early dysbiosis or recovery phase

These pathways interact. Butyrate production and hydrogen sulfide production compete for substrate. Methane production depends on the byproducts of bacterial fermentation. Reading the full picture rather than optimizing a single marker is what makes this approach useful for gut health optimization. For the wider scientific context, see our overview of gut microbiome science and VOC analysis.

How Food Shapes Your Molecular Signature

Fiber and fermentation. The most direct relationship is between fiber intake and short-chain fatty acid production. Fiber is substrate; more fermentable fiber means more material for butyrate producers. The type matters as well, since different fibers are fermented by different taxa. Inulin is preferentially fermented by Bifidobacterium species, resistant starch by certain Roseburia and Faecalibacterium species, and pectin by others, so different fiber profiles produce subtly different volatilome signatures.

Protein and putrefaction. Higher protein intake, especially from animal sources, provides more substrate for protein-degrading bacteria, which typically raises hydrogen sulfide, volatile amines and indole metabolites. This does not make higher-protein diets problematic; it means they engage a different set of metabolic pathways. In vitro fermentation work tracking VOC output in real time confirms that substrate composition rapidly reshapes the volatile profile (Dell'Olio et al., Scientific Reports, 2024).

Fat and bile acids. Dietary fat stimulates bile acid secretion, and the microbiota converts primary bile acids into secondary ones. Primary bile acids are not volatile, but the VOC profile can still reflect the metabolic state that fat digestion creates.

Timing. Meal timing and eating pattern influence microbiota oscillations and metabolite cycling, so a VOC profile is not static across a day (Bautista et al., Applied Microbiology and Biotechnology, 2025).

The practical implication is that dietary context is essential. Someone who recently increased fiber may show transitional changes; someone who shifted to lower-carbohydrate eating should expect a different baseline than before. Without that context, it is easy to mistake normal metabolic adaptation for dysbiosis.

Hypothetical scenario. As an illustrative scenario, imagine two people whose sequencing results look broadly similar at genus level. One eats around 35 grams of mixed plant fiber a day; the other eats a high-protein, low-fiber pattern. Based on the mechanisms above, the first would be expected to show a volatilome weighted toward short-chain fatty acids with low branched-chain fatty acids and modest indoles, while the second would be expected to show elevated iso-butyrate, iso-valerate, indole, skatole and sulfur volatiles. This scenario is constructed to illustrate the published chemistry. It is not a real person, not a SNIFR result, and not a prediction about any individual.

The Time Dimension

Your microbiota has a circadian rhythm, and the volatilome oscillates with it. Bacterial abundance patterns change across the day and night, and production of key metabolites including short-chain fatty acids and bile acids fluctuates in step.

The relationship is bidirectional. Your circadian clock influences the microbiota through feeding behavior, immune signaling and epithelial renewal, while microbial metabolites in turn influence host circadian physiology through nuclear receptor signaling. Bautista and colleagues review the evidence in both directions, including the disruption seen in shift work and irregular feeding (Applied Microbiology and Biotechnology, 2025). Practically, this means timing matters: a morning sample may differ from an evening one, and a single measurement should not be read in isolation from the time of day or the accumulated context of the preceding day.

Individual Variability and Why Personalization Matters

One of the more robust findings in microbiome research is how substantial baseline variability is between people. Rothschild and colleagues analyzed over 1,000 individuals and concluded that environment dominates over host genetics in shaping gut microbiota, with genetic ancestry explaining a small fraction of compositional variance (Nature, 2018). Attempts to impose a universal optimal profile across diverse humans therefore tend to fail.

A second, easily missed source of variability is absolute microbial load. Vandeputte and colleagues introduced quantitative microbiome profiling and showed that total microbial cell counts vary roughly tenfold between individuals, which means that relative abundance data alone can badly misrepresent what is actually happening in a given gut (Nature, 2017). Metabolite output scales with cells, not with percentages.

Several other factors contribute.

• Host genetics affecting immune function, barrier properties and metabolic capacity influence which microbes thrive, though as Rothschild and colleagues showed, less than most people assume.
• Early life factors including delivery mode, breastfeeding history and early antibiotic exposure shape the developmental trajectory of the microbiota.
• Medication history, particularly antibiotics and proton pump inhibitors, has lasting effects on composition.
• Dietary patterns and food culture influence which taxa colonize and persist.
• Individual metabolic capacity, with some people appearing to be consistently higher or lower short-chain fatty acid producers on similar diets.

The consequence is that meaningful interpretation means tracking change from your own baseline rather than comparison against a population average. That is the principle SNIFR's development work is built around: capture a personal baseline volatilome, then use subsequent measurements to follow how the signature changes in response to dietary or lifestyle modifications.

Honest Limitations of VOC Interpretation

VOC analysis provides a high-resolution view of volatile metabolite production. It is non-invasive, relatively accessible, and captures functional information sequencing cannot. Those are genuine strengths. The limitations deserve equal attention.

• Volatility bias. By definition we see only the volatile subset. Less volatile metabolites including many secondary bile acids and signaling molecules are invisible to this method, even though they are part of the same 1,116-metabolite space Zierer and colleagues characterized.
• Single time point limits. The volatilome oscillates, so one measurement without temporal context can mislead.
• Relative versus absolute measurement. Without a measure of microbial load, proportional shifts can be misread, which is the core lesson of quantitative microbiome profiling.
• Causality remains unclear. Does elevated methane cause slow transit, or does slow transit create conditions where methanogens flourish? The relationship is often bidirectional and the precise causal structure is still being worked out.
• Standardization challenges. Different analytical platforms and protocols yield somewhat different results, and the field is not yet at the point where every laboratory uses identical methods.
• Interpretive complexity. A volatilome is not a code that decrypts into a single health score. It requires contextual interpretation.

None of this negates the value of the approach. It means VOC data should be interpreted thoughtfully, as one piece of a larger picture rather than as a definitive diagnostic.

From Data to Personalized Insights

Translating a raw volatile profile into something actionable involves several layers. First, the analytical chemistry produces a list of detected compounds and relative concentrations. Second, that data is read against your own prior samples rather than an external population average. Third, clinical context including symptoms, diet, medication history and goals informs interpretation. Fourth, pattern recognition identifies the ecological signature: is fermentation or putrefaction dominant, is the short-chain fatty acid profile healthy, are dysbiotic markers present. Fifth, findings are read against the broader research literature, including work showing that fecal VOC profiles can separate gastrointestinal disease states from healthy controls (Dalis et al., Microorganisms, 2023). Finally, the result is translated into specific, personalized insights rather than a bare number.

Volatilome data is most useful alongside other information: symptom tracking, dietary logging, conventional laboratory work, and above all response to a specific intervention. Did increasing fermentable fiber shift the profile toward more butyrate? Did reducing high-sulfur foods lower sulfide output? Those personal experiments are where this kind of data earns its keep.

SNIFR's at-home monitoring platform is in development and has not been clinically validated. It is designed to surface patterns and support gut health optimization, not to diagnose or predict disease.

Frequently Asked Questions

What does VOC data actually tell me about my gut?

VOC data tells you what your gut bacteria are doing metabolically, not simply which species are present. In TwinsUK, gut microbial composition explained on average 67.7 percent of fecal metabolite variation while host genetics explained about 17.9 percent. The balance between fermentation products such as butyrate and putrefaction products such as sulfur compounds and indoles describes which pathways currently dominate.

Why is butyrate considered a marker of a healthy gut microbiome?

Butyrate is the preferred fuel for the cells lining the colon and supports barrier integrity, so a strong butyrate signature suggests fermentation is proceeding well. It also inhibits histone deacetylases, which research links to anti-inflammatory effects and regulatory T cell development. Its main producer, Faecalibacterium prausnitzii, is consistently depleted in Crohn's disease.

What proportions of short-chain fatty acids are normal?

Colonic measurements reported by Cummings and colleagues in 1987 put acetate, propionate and butyrate at roughly a 60:20:20 molar ratio, with total concentrations around 100 millimoles per litre in the proximal colon and falling distally. Those three account for the great majority of the colonic short-chain fatty acid pool. Individual variation around that ratio is substantial.

What does it mean if my stool smells strongly of sulfur?

Strong sulfur odor reflects active hydrogen sulfide production, usually from sulfate-reducing or cysteine-metabolizing bacteria. Some sulfide production is normal and even useful as a signaling molecule. Research associates a profile where sulfur compounds dominate alongside low butyrate with a shift toward protein degradation rather than carbohydrate fermentation.

Does my gut microbiome change during the day?

Yes. The gut microbiota shows diurnal rhythms in both composition and metabolic output, so the volatilome oscillates rather than sitting still. The relationship runs in both directions, with host circadian timing shaping the microbiota and microbial metabolites feeding back on host physiology. A sample collected in the morning can differ from one collected in the evening.

How does diet change my gut microbiome's molecular signature?

Diet is the strongest single influence on your volatilome. More fermentable fiber gives butyrate producers more substrate and redirects microbial tryptophan metabolism toward indole-3-propionic acid, while higher protein intake increases sulfur compounds, volatile amines, indole and skatole. Shifts of this kind are measurable within days to weeks.

What are the limits of interpreting volatile organic compound data?

VOC analysis captures only the volatile fraction of the metabolome, so less volatile metabolites stay invisible. Total microbial load varies roughly tenfold between people, so relative measurements can mislead without a quantitative anchor. Causality is often unclear and standardization across laboratories remains incomplete.

References

• Zierer J, Jackson MA, Kastenmüller G, et al. The fecal metabolome as a functional readout of the gut microbiome. Nature Genetics. 2018;50(6):790-795. doi:10.1038/s41588-018-0135-7
• Cummings JH, Pomare EW, Branch WJ, et al. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28(10):1221-1227. doi:10.1136/gut.28.10.1221
• Parada Venegas D, De la Fuente MK, Landskron G, et al. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Frontiers in Immunology. 2019;10:277. doi:10.3389/fimmu.2019.00277
• Mann ER, Lam YK, Uhlig HH. Short-chain fatty acids: linking diet, the microbiome and immunity. Nature Reviews Immunology. 2024;24(8):577-595. doi:10.1038/s41577-024-01014-8
• Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proceedings of the National Academy of Sciences. 2008;105(43):16731-16736. doi:10.1073/pnas.0804812105
• Blachier F, Andriamihaja M, Larraufie P, et al. Production of hydrogen sulfide by the intestinal microbiota and epithelial cells and consequences for the colonic and rectal mucosa. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2021;320(2):G125-G135. doi:10.1152/ajpgi.00261.2020
• Qi Q, Zhang H, Jin Z, et al. Hydrogen sulfide produced by the gut microbiota impairs host metabolism via reducing GLP-1 levels in male mice. Nature Metabolism. 2024;6(8):1601-1615. doi:10.1038/s42255-024-01068-x
• Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nature Communications. 2018;9(1):3294. doi:10.1038/s41467-018-05470-4
• Li X, Zhang B, Hu Y, et al. New insights into gut-bacteria-derived indole and its derivatives in intestinal and liver diseases. Frontiers in Pharmacology. 2021;12:769501. doi:10.3389/fphar.2021.769501
• Sinha AK, Laursen MF, Brinck JE, et al. Dietary fibre directs microbial tryptophan metabolism via metabolic interactions in the gut microbiota. Nature Microbiology. 2024;9(8):1964-1978. doi:10.1038/s41564-024-01737-3
• Hoegenauer C, Hammer HF, Mahnert A, et al. Methanogenic archaea in the human gastrointestinal tract. Nature Reviews Gastroenterology & Hepatology. 2022;19(12):805-813. doi:10.1038/s41575-022-00673-z
• Vandeputte D, Kathagen G, D'hoe K, et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature. 2017;551(7681):507-511. doi:10.1038/nature24460
• Bautista J, Ojeda-Mosquera S, Altamirano-Colina A, et al. Bidirectional interactions between circadian rhythms and the gut microbiome. Applied Microbiology and Biotechnology. 2025;109(1):39. doi:10.1007/s00253-025-13570-7
• Calabrese FM, Genchi VA, Serale N, et al. Gut microbiota and fecal volatilome profile inspection in metabolically healthy and unhealthy obesity phenotypes. Journal of Endocrinological Investigation. 2024;47(12):3077-3090. doi:10.1007/s40618-024-02379-2
• Dell'Olio A, Rubert J, Capozzi V, et al. Non-invasive VOCs detection to monitor the gut microbiota metabolism in-vitro. Scientific Reports. 2024;14:15479. doi:10.1038/s41598-024-66303-7
• Dalis C, Mesfin FM, Manohar K, et al. Volatile Organic Compound Assessment as a Screening Tool for Early Detection of Gastrointestinal Diseases. Microorganisms. 2023;11(7):1822. doi:10.3390/microorganisms11071822
• Garner CE, Smith S, de Lacy Costello B, et al. Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. The FASEB Journal. 2007;21(8):1675-1688. doi:10.1096/fj.06-6927com
• Rothschild D, Weissbrod O, Barkan E, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018;555(7695):210-215. doi:10.1038/nature25973
• Evenepoel P, Meijers BKI, Bammens BRM, et al. Uremic toxins originating from colonic microbial metabolism. Kidney International. 2009;76(Suppl 114):S12-S19. doi:10.1038/ki.2009.402

SNIFR is designed to provide insights about gut health patterns, not to diagnose or treat medical conditions. Individual results may vary as gut health is influenced by numerous factors including diet, stress, sleep, and genetics. SNIFR is currently in development, and features described may evolve before commercial release.